Psychiatric Multi-omics and Neuroimaging Project
Recruiting · NCT06580860 · Observational (researchers observe without assigning treatment) · Lead sponsor: mingjun Zhong
View the official record on ClinicalTrials.gov →Interventions studied
Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids
What this trial is about
This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.
Who can take part
Age range
13 Years to 35 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age)
- Course of disease: \<24 months
- Priority is given to patients who have never taken medicine or duration of drug use \< 2 weeks
- No nuclear magnetic contraindications.
Exclusion criteria
- Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence
- Have a major physical disease or infectious disease
- History of coma and serious neurological disease 4.MRI contraindications.
Where it is running
2 locations listed.
- The Second Xiangya hospital of central south univerity - Changsha, Hunan, China
- The Second Xiangya hospital of central south univerity - Changsha, Hunan, China